First identified in human plasma in the 1970s, this small tripeptide glycyl-L-histidyl-L-lysine, bound to a copper ion has become one of the most extensively referenced compounds in dermal and wound-healing research literature, largely because its copper-binding structure gives it a distinct mechanism from most other peptide sciences on the market

the present invention furthermore relates to a BPC peptide salt or a pharmaceutical or diagnostic composition according to the above wherein the general formula (II) is the present invention relates in particular to a BPC peptide salt or a pharmaceutical or diagnostic composition a BPC peptide salt or a pharmaceutical or diagnostic composition comprising a salt of a BPC peptide according to the above general formula (I) wherein the peptide is selected from the group consisting of: the peptides may be linked to other functional and/or structural moieties such as carbohydrates, fats, proteins or peptides, antibodies, receptors, hormones, cytotoxic substances, marker substances, dyes, radioactive labels, immunomodulatory agents, drugs, carriers, targeting or signalling substances, etc
Visual symptoms are common in this condition and patients may report bilateral blurry vision and transient visual obscurations (TVOs) as well as pulse synchronous tinnitus (PST) [7]
At minimum, eliminate alcohol for 48 hours before your first dose and limit consumption throughout your treatment